The Acanthus Research Blog

Keep up-to-date on the latest news at Acanthus Research including scientific events, global conferences, new products, and other company related news. You can also subscribe to our newsletter for ARI updates delivered right to your inbox!

New Products

March 21, 2019
Acanthus Research Inc. (ARI) is a leading Canadian company developing and manufacturing pharmaceutical reference standards. Our team of experienced scientists is adding new products to our portfolio every day, every...
Read More

Nilotinib Potentially Genotoxic Impurities

February 2, 2015
Analytical reference standards of three potentially genotoxic impurities of nilotinib (Tasigna) are now available from Acanthus Research: Nilotinib Genotoxic Impurity 1 (CAS No. 641571-11-1), Nilotinib Genotoxic Impurity 2 (CAS No.1157857-29-8), and...
Read More

Lapatinib Potentially Genotoxic Impurities

February 1, 2015
Analytical reference standards of two potentially genotoxic impurities of lapatinib (Tykerb, Tyverb) are now available from Acanthus Research Inc.: Lapatinib Genotoxic Impurity 1 (CAS No. 202197-26-0) and Lapatinib Genotoxic Impurity 2 (CAS...
Read More

Montelukast Impurity Standards

May 10, 2014
Acanthus Research Inc. now offers all USP impurity reference standards for montelukast sodium, as listed in the USP monograph as well as montelukast lactone potential process impurity reference standard. The...
Read More